Bayer launches biotech innovation platform in China
Bayer Co.Lab AdVenture platform will accelerate biotech innovation through global investment networks
Bayer Co.Lab AdVenture platform will accelerate biotech innovation through global investment networks
Encouraging early detection and breaking the silence around men’s health
Tegoprazan, a novel patented molecule indicated for acid-related gastrointestinal diseases, is launched in India under the brand name PCAB
Designed as an “AI-as-a-Service” platform, VECURA aims to reduce the traditional therapeutic drug discovery timeline of 10–12 years to just a few hours.
The FDA is beginning rulemaking to close the “adequate provision” loophole
Nu Nutridac is a nutritional replenisher for neurodegenerative and anxiety-related disorders
Program provides access to Lilly-trained artificial intelligence to help accelerate breakthrough medicines
New unit boosts innovation in liposomal delivery technologies with 8,500 MT capacity and export-ready production
Breakthrough UNITY 4D Phaco delivers up to 2X faster nucleus removal and 41% less energy into the eye
Subscribe To Our Newsletter & Stay Updated